Assembly Biosciences Ownership | Who Owns Assembly Biosciences?
Assembly Biosciences Ownership Summary
Assembly Biosciences is owned by 122.10% institutional investors, 32.30% insiders. Gilead sciences is the largest institutional shareholder, holding 58.85% of ASMB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.01% of its assets in Assembly Biosciences shares.
ASMB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Assembly Biosciences | 122.10% | 32.30% | -54.40% |
| Sector | Healthcare Stocks | 42.53% | 10.81% | 46.67% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Gilead sciences | 4.51M | 58.85% | $115.34M |
| Farallon capital management | 1.23M | 16.03% | $31.43M |
| Ra capital management | 1.02M | 13.33% | $26.12M |
| Commodore capital lp | 1.00M | 13.06% | $25.60M |
| Vanguard group | 502.11K | 6.56% | $12.85M |
| Frazier life sciences management | 456.25K | 5.96% | $11.68M |
| Blackstone | 447.79K | 5.85% | $11.46M |
| Point72 asset management | 296.02K | 3.87% | $7.58M |
| Parkman healthcare partners | 250.98K | 3.28% | $6.43M |
| Franklin resources | 238.17K | 3.11% | $11.41M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Gilead sciences | 4.51M | 6.44% | $115.34M |
| B group | 175.71K | 3.31% | $4.50M |
| Commodore capital lp | 1.00M | 1.25% | $25.60M |
| Patient square capital lp | 135.18K | 0.93% | $3.46M |
| Parkman healthcare partners | 250.98K | 0.67% | $6.43M |
| Monimus capital management, lp | 42.07K | 0.66% | $1.08M |
| Frazier life sciences management | 456.25K | 0.35% | $11.68M |
| Stempoint capital lp | 66.13K | 0.34% | $1.69M |
| Ra capital management | 1.02M | 0.32% | $26.12M |
| Palumbo wealth management | 34.80K | 0.28% | $890.83K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gilead sciences | 4.51M | 6.44% | 2.30M |
| Farallon capital management | 1.23M | 0.13% | 1.23M |
| Ra capital management | 1.02M | 0.32% | 1.02M |
| Commodore capital lp | 1.00M | 1.25% | 1.00M |
| Frazier life sciences management | 456.25K | 0.35% | 456.25K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -23.86K |
| Squarepoint ops | - | - | -18.98K |
| B group | 175.71K | 3.31% | -13.64K |
| Man group | - | - | -13.23K |
| American century companies | - | - | -11.80K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Farallon capital management | 1.23M | 0.13% | 1.23M | $31.43M |
| Ra capital management | 1.02M | 0.32% | 1.02M | $26.12M |
| Commodore capital lp | 1.00M | 1.25% | 1.00M | $25.60M |
| Frazier life sciences management | 456.25K | 0.35% | 456.25K | $11.68M |
| Blackstone | 447.79K | 0.05% | 447.79K | $11.46M |
Sold Out
| Holder | Change |
|---|---|
| Frazier financial advisors | -1.00 |
| Royal bank of canada | -53.00 |
| Ameriflex group | -83.00 |
| Tower research capital llc (trc) | -250.00 |
| Raymond james financial | -250.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 43 | 26.47% | 9,347,787 | 196.88% | 122 | 7.22% | 30 | 130.77% | 4 | -50.00% |
| Jun 30, 2025 | 34 | -5.56% | 3,148,666 | -0.85% | 41 | 2.30% | 13 | -18.75% | 8 | -20.00% |
| Mar 31, 2025 | 36 | 2.86% | 3,175,639 | -0.32% | 42 | 1.81% | 16 | -23.81% | 10 | 42.86% |
| Dec 31, 2024 | 35 | 16.67% | 3,185,761 | 210.20% | 48 | 18.52% | 21 | 61.54% | 7 | - |
| Sep 30, 2024 | 30 | 7.14% | 1,026,987 | -12.62% | 16 | 3.73% | 13 | -13.33% | 7 | 40.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 127.52K | 2.01% | -2.79K |
| Vanguard US Total Market Shares ETF | 114.78K | 1.53% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 68.61K | 1.08% | -32.59K |
| Franklin Biotechnology Discv A(acc)USD | 166.20K | 1.07% | 166.20K |
| Federated Hermes MDT Small Cap Growth IS | 25.39K | 0.33% | - |
| Federated Hermes MDT SCG Institutional | 25.39K | 0.33% | - |
| Vanguard Strategic Small-Cap Equity Inv | 17.72K | 0.23% | - |
| Bridgeway Ultra-Small Company Market | 13.75K | 0.22% | - |
| Fidelity Extended Market Index | 27.00K | 0.17% | 4.20K |
| Extended Equity Market Fund K | 13.08K | 0.17% | 8.11K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 08, 2025 | GILEAD SCIENCES, INC. | - | Buy | $2.30K |
| Aug 08, 2025 | GILEAD SCIENCES, INC. | - | Buy | $24.80M |
| Aug 08, 2025 | GILEAD SCIENCES, INC. | - | Buy | $24.80M |
| Mar 31, 2025 | McHutchison John G | - | Sell | $7.46K |
| Mar 31, 2025 | Bjorkquist Jeanette M | Principal Accounting Officer | Sell | $1.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 4 |
| 2024 Q4 | 6 | 3 |
| 2024 Q3 | 2 | 2 |
| 2024 Q2 | 2 | 10 |
ASMB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools